GeoVax Announces 100% Protection Data from Marburg Virus Vaccine Study
July 29, 2019 09:00 ET
|
GeoVax, Inc.
Study Data Adds to Similar Efficacy Previously Reported for GeoVax’s Ebola and Lassa Fever Vaccines ATLANTA, GA, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB:...
GeoVax Presents HIV Vaccine Study Data
July 24, 2019 09:00 ET
|
GeoVax, Inc.
Presentation Made at the 10th International AIDS Society Conference on HIV Science ATLANTA, GA, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...